Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03709667 · ClinicalTrials.gov registry record · Early Phase 1
Exercise in Methamphetamine Use Disorder Upregulation and Neural Function
A Early Phase 1 study of Methamphetamine Abuse, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 113
- Enrollment target
- 1
- Study location
NCT03709667: Completed Early Phase 1 study of Methamphetamine Abuse, sponsored by University of California, Los Angeles.
NCT03709667 is a Early Phase 1 study of Methamphetamine Abuse that has completed, run by University of California, Los Angeles. The registered enrollment target is 113 participants, below the 201-participant average among 15 other Methamphetamine Abuse trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03709667, a Early Phase 1 study of Methamphetamine Abuse, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 113 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to determine the effects of an exercise intervention and health-education program on brain dopamine receptors and on cognitive functions that have been linked to these receptors.
Primary Outcome
Dopamine D2-type receptor binding potential in the striatum measured with positron emission tomography scanning measured at baseline prior to exercise (EX) and after 8 weeks of EX (vs. CON) treatment.
Conditions Studied
Interventions
- BEHAVIORAL EX
- BEHAVIORAL CON
Study Locations (1)
California
- University of California Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2019-06-26 |
| Est. Completion | 2023-08-30 |
| Phase | Early Phase 1 |
What the finished NCT03709667 record still lists
NCT03709667 is an interventional study that assigns participants to a tested intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap, below the 201-participant average among 15 other Methamphetamine Abuse trials with a reported enrollment target (44% lower).
The record links to 1 condition, with Methamphetamine Abuse appearing as the primary indexed condition, and to 2 interventions - of which EX is the first listed.
NCT03709667 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03709667 about?
NCT03709667 is a clinical study titled "Exercise in Methamphetamine Use Disorder Upregulation and Neural Function". The purpose of this research study is to determine the effects of an exercise intervention and health-education program on brain dopamine receptors and on cognitive functions that have been linked to these receptors.
What is the current status of trial NCT03709667?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 113 participants. The study started on 2019-06-26. Estimated completion is 2023-08-30.
What conditions does trial NCT03709667 study?
This clinical trial studies the following conditions: Methamphetamine Abuse.
What interventions are being tested in trial NCT03709667?
The interventions under investigation include: EX (BEHAVIORAL), CON (BEHAVIORAL).
Who is sponsoring clinical trial NCT03709667?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03709667 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Methamphetamine Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03709667's enrollment target sits among peer trials
113 6th of 15 higher than 10 of 15 other Methamphetamine Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Methamphetamine Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse
COMPLETED · Early Phase 1
-
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine
RECRUITING · Phase 2
-
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
RECRUITING · Phase 3
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Theta Burst TMS for Treatment of Methamphetamine Use Disorder
RECRUITING · NA
-
rTMS for Craving in Methamphetamine Use Disorder
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00748254 · 113 participants
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
- NCT04753190 · 113 participants · NA
Light Timing Study
- NCT05799248 · 113 participants · Phase 3
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
- NCT07216105 · 113 participants · Phase 1
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI